Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VOQUILY 1MG/ML SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/VOQUILY 1MG/ML SOLUCION ORAL

Approved

STANDARD

VOQUILY 1MG/ML SOLUCION ORAL

Clinigen Healthcare B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Aug 8, 2022
Approval ID: a3788a100ea7d46b
Company: Clinigen Healthcare B.V.
Type: Standard

Approval Details

Approval Id: a3788a100ea7d46b
Drug Cima Aemps Name: VOQUILY 1MG/ML SOLUCION ORAL
Register Number: 88027
Holder Company Name: Clinigen Healthcare B.V.
Marketing Company Name: Clinigen Healthcare B.V.
Authorization Date: 2022-08-08
Dosage Form: SOLUCIÓN ORAL
Dose: 1 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Clinigen Healthcare B.V.

Active Ingredients

MELATONINA

1 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 8, 2022

Approval ID

a3788a100ea7d46b

Type

Standard

Back to CIMA-AEMPS Approvals